Back To Search Instructions
Protocols
7 protocols meet the specified criteria
Disease Site: Myeloid and Monocytic Leukemia
Protocol No.TitleStatus
0500000226Arizona Lymphoid Tissue and Blood Repository (ALTBR)Open
1100000610A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications (10-CBA)Open
1200000148A Multicenter Safety Study of Unlicensed Investigational Cryopreserved Cord Blood Units (CBUs) Manufactured by the National Cord Blood Program (NCBP) and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients (6637-01)Open
1607716638A Phase 3, Double-Blind, Placebo-Controlled Study of Quizartinib (AC220) Administered in Combination with Induction and Consolidation Chemotherapy, and Administered as Maintenance Therapy in Subjects 18 to 75 Years Old with Newly Diagnosed FLT3-ITD (+) Acute Myeloid LeukemiaOpen
1609875338A Phase 1 Dose Escalation Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous PF-06747143, Administered as Single Agent or in Combination with Standard Chemotherapy in Adult Patients with Acute Myeloid LeukemiaOpen
1701114637Connect® MDS/AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease RegistryOpen
SGN33A-005A Randomized, Double-blind Phase 3 Study of Vadastuximab Talirine (SGN-CD33A) versus Placebo in Combination with Azacitidine or Decitabine in the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)Not Open